Trial Profile
The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2013
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 21 Aug 2013 New trial record